Business Context and Reporting Period
This Form 8-K is a current report filed by BioSig Technologies, Inc. (not Streamex Corp.) on July 13, 2017. The registrant is an emerging growth company incorporated in Delaware with principal executive offices in Minneapolis, Minnesota. The report details the consummation of a sixth closing under a Unit Purchase Agreement dated April 6, 2017.
Key Financial Metrics
The filing reports specific capital raising activity but does not provide comprehensive financial statements such as revenue, profit, cash flow, or debt levels.
- Capital Raised (Current Closing): $400,500
- Securities Issued (Current Closing): 267,002 Units
- Unit Composition: 1 share of Common Stock + 1 warrant to purchase 0.5 shares
- Price per Unit: $1.50
- Warrant Exercise Price: $1.50 per share
- Total Capital Raised (Aggregated): $1,640,398 (including prior closings from April through June 2017)
- Total Units Issued (Aggregated): 1,093,602 Units
Material Changes
The primary material change is the issuance of unregistered equity securities to accredited investors. This represents the sixth tranche of funding under the April 2017 Purchase Agreement. The securities were offered and sold in reliance on the exemption from registration under Section 4(a)(2) and Regulation D (Rule 506) of the Securities Act of 1933. No material changes to revenue, operating margins, or debt obligations are disclosed in this specific filing.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure regarding the unregistered nature of the securities. The transaction was executed with accredited investors who entered into a Registration Rights Agreement dated April 6, 2017.
Investor Verification Checklist
- Verify the total number of outstanding shares and warrants following this issuance to assess dilution.
- Confirm the company's current cash position and burn rate, as this filing only details capital inflow, not operational usage.
- Review the full text of the Unit Purchase Agreement and Registration Rights Agreement for specific terms regarding future funding obligations or investor rights.
- Check subsequent filings for the registration status of the Investor Shares and Warrants, as they were initially issued unregistered.